CLINICAL_TRIALS
trial_result
· 2016-03-02
Clinical Trial Update: A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004) [Phase 1]
Summary
A Phase 1 study evaluating grazoprevir (MK-5172) in hepatitis C-infected male participants has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2016-03-02